Pharmaceutical Development - Unibest Industrial Co., Ltd.

Blogs

Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Case Study of Flow Chemistry in the Synthesis of Pharmaceutical Ingredient Belzutifan
2024-04-23

IntroductionIn a previous article, we discussed when to consider using flow chemistry over conventional batch processes for chemical synthesis. One compelling example highlighting the advantages of flow chemistry comes from the manufacturing route development for belzutifan, a recently approved drug Read More
Scaling the Everest of Pharma Synthesis: A Deep Dive into Eribulin's Journey
2024-04-19

As one steps into the realm of pharmaceutical discovery, the name Eribulin, also known as Halaven, rings a powerful note. First approved in 2010 by Eisai, this non-peptide drug, intricate in its synthesis and impressive in the magnitude of its medical impact, has been nothing short of groundbreaking Read More
The Melt-In-Your-Mouth Medicine
2024-03-01

Why Choose Orally Dissolving Tablets (ODTs)?Orally dissolving tablets (ODTs) have revolutionized the pharmaceutical industry and patient care by enhancing drug life-cycle management and offering convenient dosing for patients who have difficulty swallowing, such as children, the elderly, and psychia Read More
Cancer, radiopharma & RDCs
2024-02-27

Market potential of radiopharma & RDCsRDCs are currently being developed for cancer. According to the WHO IARC, in 2022, the five most common cancers resulted in 19,956,054 new cases and 9,736,520 deaths. It is estimated that by 2050, the incidence of all cancers will reach 35.3 million. Consequentl Read More
Stability of Pharmaceutical Industry Supply Chains Against the Backdrop of Deglobalization
2024-02-23

In the tide of globalization, supply chains, as the important link connecting the economies of various countries, play an extremely important role. However, in recent years, the trend of deglobalization has gradually emerged, bringing unprecedented challenges to global supply chains. Especially in t Read More
Radionuclide Drug Conjugates (RDC): A New Star in Precision Medicine
2024-02-08

In today's pharmaceutical industry, an innovative therapeutic known as "Radionuclide Drug Conjugates" (RDC) is gradually making its mark. In the 2023 FDA's approval, there is one drug called flotufolastat F-18 (Posluma). It is an intravenous binder to PSMA expressed on cells for PET imaging of prost Read More
The Magic Bullet in the Synthesis? - Well, Name Goes to the Molecular Building Blocks
2024-01-24

Molecular building blocks, also known as organic building blocks, are functionalized molecules that serve as the foundational components for organic synthesis. Utilized for bottom-up modular assembly, they enable the construction of molecular architectures such as supramolecular complexes, metal-org Read More
Peptide 101: A Deep Dive into Peptide Drug Market, Development Timeline, and Strategies in Delivery
2024-01-18

While everything from dietary changes to high-cost surgeries has been explored to combat diseases, therapeutics derived from peptides have risen as a powerful strategy. Over the past few years, peptide drugs have swept through the pharmaceutical market, redefining treatment approaches for various di Read More
The STNG Pathway and drug development
2024-01-17

A Novel Target: The STING PathwayInfection, cancer, and cellular damages often results in mislocalized dsDNA within the cell.The STING (Stimulator of Interferon Genes) signaling pathway is triggered through innate cyclic GMP-AMP synthase (cGAS) activation, giving the molecule cGAMP.2', 3' - cGAMP mo Read More